Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-10

Clinical Trial Update: Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunogenicity and safety of a liquid bivalent oral poliomyelitis vaccine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liquid bivalent oral poliomyelitis vaccine

Snippet

Sponsor: PATH | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED | Results posted: 2020-03-10